Bristol-Myers Squibb Company (BMY) has shown a revenue growth rate of 0.0% year-over-year. Earnings have grown by 0.0% in the same period.
Over the past 4 years, Bristol-Myers Squibb Company has delivered a compound annual growth rate (CAGR) of 1.0% for revenue and 0.2% for earnings.
Historical revenue and net income for Bristol-Myers Squibb Company
Annual percentage change in revenue and earnings
Historical EPS trends for Bristol-Myers Squibb Company
Earnings per share (EPS) is a key metric that shows how much profit Bristol-Myers Squibb Company generates for each share of stock. Over the past 4 years, EPS has grown at a CAGR of 2.4%.